Resource Details


Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK

Author(s)Curtis G. Gemmell; David I. Edwards; Adam P. Fraise; F. Kate Gould; Geoff L. Ridgway; Rod E. Warren ; and on behalf of the Joint Working Party of the British Society for Antimicrobial Chemotherapy; Hospital Infection Society and Infection Control Nurses Association
AbstractThe Department of Health committee (SACAR) asked a joint working party of infection experts to revise previous guidelines on the prevention and control of MRSA infections and to extend the scope to include treatment and prophylaxis of MRSA infections and also laboratory diagnosis & susceptibility testing of MRSA. One of a set of three, these are the first UK guidelines focussing on the treatment and prophylaxis of MRSA infection. These evidence-based guidelines were produced after an extensive literature review and were further informed by antibiotic susceptibility data on MRSA from the UK. Recommendations are given for the treatment of common infections caused by MRSA, elimination of MRSA from carriage sites and prophylaxis of surgical site infection. There are several antibiotics currently available that are suitable for use in the management of this problem and potentially useful new agents are continuing to emerge.
Date of publishing02/28/2006
Date of last review by us12/21/2011
Bookmark this page Email this page to a friend Print this page


Full ReviewReview byQuestions this resource addresses
Click here for full reviewJane Mani-Saada with assistance from Manjit Affley PhD BPharm(Hons) MRPharmS (Senior Scientific Adviser Pfizer Anti-infectives) These evidence based guidelines provide updated guidance for prophylaxis and treatment of MRSA in the UK. . . .


Twitter FeedTwitter Feed